Skip to main content
Dermatology Diagnostic Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, UK, Germany, Japan - Size and Forecast 2024-2028

Dermatology Diagnostic Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, UK, Germany, Japan - Size and Forecast 2024-2028

Published: Jul 2024 176 Pages SKU: IRTNTR70805

Market Overview at a Glance

$10.87 B
Market Opportunity
10.87%
CAGR
9.53
YoY growth 2023-2024(%)

Dermatology Diagnostic Devices Market Size 2024-2028 

The dermatology diagnostic devices market size is forecast to increase by USD 10.87 billion at a CAGR of 10.87% between 2023 and 2028. The market is experiencing significant advancements, driven by the increasing prevalence of skin diseases such as melanoma and autoimmune conditions. To address the lack of accurate diagnosis and the shortage of skilled technicians, innovative technologies like augmented reality (AR) and virtual reality (VR) are being integrated into diagnostic tools. Spatial computing, which combines AR and VR, enables more precise analysis and diagnosis. Wearable devices, such as smartwatches, patches, and smart clothing equipped with trackers and sensors, are also gaining popularity for the early detection and monitoring of skin conditions. Battery life remains a crucial factor in the adoption of these devices, as prolonged usage is essential for effective monitoring. The integration of these advanced technologies into dermatology diagnostic devices is revolutionizing the industry and improving patient outcomes.

Dermatology Diagnostic Devices Market Size

 Request Free Sample

The market is witnessing significant growth due to the increasing prevalence of skin disorders and the growing preference for non-invasive diagnostic methods. Dermatologists are increasingly relying on advanced technologies to provide accurate diagnoses and develop effective treatment plans for their patients. Several technology advancements are driving the growth of the market. Infrared imaging, ultrasound, and optical coherence tomography are some of the technologies that are revolutionizing the diagnosis and treatment of various skin conditions. These technologies enable early detection and diagnosis of skin disorders, leading to better treatment outcomes.

Furthermore, demographic trends, such as an aging population and rising awareness of skin health, are also fueling the demand for dermatology diagnostic devices. According to the American Academy of Dermatology, over 90% of Americans will develop a skin condition at some point in their lives. Moreover, the increasing prevalence of chronic diseases and lifestyle-related disorders, such as cardiovascular diseases and diabetes, are leading to an increased focus on preventive healthcare and early diagnosis. Smartphone-based healthcare devices are gaining popularity in the market due to their convenience and affordability. These devices use wireless connectivity to transmit patient data to healthcare providers, enabling remote diagnosis and consultation.

Moreover, lifestyle management tools, such as fitness tracking capabilities, wearable activity monitors, and activity trackers, are also being integrated into these devices to provide a holistic approach to patient care. Patient preference for non-invasive diagnostic methods is another factor driving the growth of the market. Non-invasive diagnostic methods, such as infrared imaging and optical coherence tomography, offer several advantages over traditional diagnostic methods, including minimal discomfort, faster results, and improved accuracy. The use of biosensors and mHealth intelligence is also gaining momentum in the market.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • End-user
    • Hospitals
    • Clinics
    • Diagnostic labs
  • Type
    • Imaging devices
    • Microscopes
    • Immunoassays
    • Molecular diagnostics
    • Others
  • Geography
    • North America
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • China
      • Japan
    • Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. In the market, hospitals are projected to experience notable growth in terms of annual expansion rate compared to clinics and diagnostic labs. These devices offer numerous advantages to hospitals and clinics, including enhanced patient care and satisfaction, streamlined operations at the point of care, and cost savings through improved operational efficiency. In 2023, hospitals emerged as the primary revenue drivers for the market due to the increasing prevalence of skin diseases and the availability of specialized professionals. Consumer-grade and clinical-grade dermatology diagnostic devices are increasingly being adopted for remote patient monitoring and home healthcare applications. MHealth intelligence, activity trackers, and other digital health technologies are transforming the diagnosis and management of chronic diseases and lifestyle-related disorders.

Moreover, hospitals are integrating these advanced tools into their care delivery models to provide personalized and convenient care to patients. The market in North America is expected to expand significantly due to the increasing burden of chronic diseases, growing awareness of early disease detection, and the adoption of digital health technologies. The market is also driven by the presence of major market players, advanced healthcare infrastructure, and favorable reimbursement policies. The market is experiencing steady growth due to the increasing prevalence of skin diseases, the adoption of digital health technologies, and the integration of remote patient monitoring and home healthcare applications.

Furthermore, hospitals are the major revenue contributors to the market due to their ability to provide specialized care and the availability of skilled professionals. In North America, the market is expected to expand significantly due to the increasing burden of chronic diseases, favorable reimbursement policies, and the presence of major market players.

Dermatology Diagnostic Devices Market Size

Get a glance at the market share of various segments Request Free Sample

The Hospitals segment was valued at USD 7.29 million in 2018 and showed a gradual increase during the forecast period.

Regional Insights

Asia is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Dermatology Diagnostic Devices Market Share by Geography

For more insights on the market share of various regions Request Free Sample

In North America, the market is experiencing notable expansion due to several factors. The geriatric population is a significant contributor to this growth, as the prevalence of chronic and infectious skin diseases is higher among older adults. In the United States, in particular, there is a growing awareness of the importance of dermatology diagnostic tests among this demographic. Furthermore, the geriatric population is more susceptible to skin cancers, which increases the demand for advanced diagnostic tools Dermatologists rely on advanced technologies, such as infrared imaging, ultrasound, and optical coherence tomography, to provide accurate diagnosis and treatment plans for their patients. Technology advancements continue to shape the market, with patient preference playing a crucial role in driving innovation.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Market Driver

The increasing prevalence of melanoma and autoimmune skin diseases is the key driver of the market. The prevalence of skin disorders and abnormalities is on the rise, leading to an increased demand for accurate and efficient diagnostic tools in the field of dermatology. Skin issues are among the most common health concerns worldwide, surpassing conditions like hypertension, cancer, and obesity in prevalence. Autoimmune skin disorders, which result from the body's abnormal immune response to foreign substances, are a significant contributor to this trend. For instance, psoriasis, an autoimmune skin condition, affects over 3% of the adult population in the United States. Moreover, the rise in aesthetic procedures and the increasing awareness of skin cancers have further fueled the adoption of dermatology diagnostic devices.

Furthermore, tropical countries and regions with high UV radiations exposure are particularly susceptible to skin disorders and skin cancers. Additionally, the advent of smartphone-based healthcare devices is revolutionizing the industry, offering convenience and accessibility to patients.

Market Trends

The emergence of teledermatology in mobile applications is the upcoming trend in the market. Dermatology diagnostic devices have evolved significantly with the integration of advanced technologies such as augmented reality (AR), virtual reality (VR), and spatial computing. These technologies enable more accurate and efficient diagnosis of skin conditions. For instance, AR and VR can provide a more great experience for both doctors and patients, allowing for a more precise analysis of skin lesions. Additionally, battery life, trackers, smartwatches, patches, and smart clothing are essential components of these devices, ensuring continuous monitoring and real-time data transmission. In the US market, teledermatology has gained traction as an alternative to traditional in-person consultations, particularly in underserved areas.

Furthermore, Mobile applications that allow individuals to interact with doctors and share images of their skin conditions have become increasingly popular. The integration of these advanced technologies into dermatology diagnostic devices is set to transform the industry and improve patient outcomes.

Market Challenge

Lack of accurate diagnosis and shortage of skilled technicians is a key challenge affecting the market growth. The diagnostic accuracy of skin diseases poses a significant challenge for healthcare professionals, with many relying on clinical symptoms and physical examinations for diagnoses. While devices such as reflectance confocal microscopy and dermatoscopes have shown improvements in specificity and sensitivity, their reliability is not absolute. For instance, studies have shown that malignant melanomas misdiagnosed by reflectance confocal microscopy were correctly identified by dermatoscopes. This inconsistency in diagnosis results in a low referral rate to specialists and an increased need for more accurate methods. Advancements in computer vision (CV) algorithms have shown promise in categorizing skin lesions with greater accuracy than human dermatologists.

However, the gap between CV algorithms and clinical practice is not significant. As technology advances, wireless connectivity and lifestyle management tools, such as home healthcare, fitness tracking capabilities, and wearable activity monitors, are increasingly integrated into dermatology diagnostic devices. These innovations offer opportunities for more accurate and accessible diagnoses, but they also raise concerns regarding consumer privacy and cybersecurity attacks. With the advent of 5G networks, faster and more reliable data transfer is expected to revolutionize the market. In conclusion, the need for accurate and reliable diagnosis of skin diseases remains a critical issue in healthcare. While advances in technology, such as computer vision algorithms and wireless connectivity, offer promising solutions, they also present challenges related to consumer privacy, cybersecurity, and regulatory compliance. As the market for dermatology diagnostic devices continues to evolve, it is essential to prioritize these considerations to ensure the delivery of effective, accessible, and secure diagnostic solutions.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Dermatology Diagnostic Devices Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Agfa Gevaert NV: The company offers a dermatology diagnostic device called Skintell, which is a non-invasive imaging technology for visualizing skin morphology.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Abbott Laboratories
  • Agfa Gevaert NV
  • AnMo Electronics Corp.
  • Baxter International Inc.
  • Bayer AG
  • Bomtech Electronics Co. Ltd.
  • Bruker Corp.
  • Caliber Imaging and Diagnostics Inc
  • Canfield Scientific Inc.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Firefly Global
  • FotoFinder Systems GmbH
  • General Electric Co.
  • HEINE Optotechnik GmbH and Co. KG
  • Keyence Corp.
  • KIRCHNER and WILHELM plus GmbH Co. KG
  • Michelson Diagnostics Inc.
  • Microcurrent Technology Inc.
  • Strata Skin Sciences Inc

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market is witnessing significant growth due to advancements in technology and an increasing preference for non-invasive diagnostic methods. Dermatologists are leveraging innovative technologies like infrared imaging, ultrasound, and optical coherence tomography for early detection and treatment of various skin disorders, including cosmetic procedures and skin cancers. Demographic trends, such as an aging population and the rising prevalence of lifestyle-related disorders, are also driving market growth. Patient preference for home healthcare and wearable technology is transforming the market. Smartphone-based healthcare devices, wireless connectivity, and lifestyle management tools are becoming increasingly popular. Consumer privacy and cybersecurity are key concerns, with 5G networks and spatial computing offering potential solutions.

Technology advancements in the form of augmented reality (AR) and virtual reality (VR) are revolutionizing the way dermatologists diagnose and treat patients. Battery life, trackers, smartwatches, patches, and smart clothing are some of the consumer-grade devices gaining traction. Clinical-grade devices, such as those used in hospitals and research institutions, continue to dominate the market. Remote patient monitoring and home healthcare applications are driving the adoption of advanced diagnostic devices. UV radiation exposure can have a significant impact on general health and fitness, especially when it comes to skin health. To protect against potential harm, tools like HealthPulse TestNow can help individuals monitor and manage their health more effectively. Additionally, protecting personal health data, such as Protected Health Information (PHI), is critical when using these health technologies to ensure privacy and compliance with regulatory standards. Chronic diseases, such as cardiovascular diseases and nonmelanoma cancer, are major indications for these devices. Retail pharmacies and online distribution channels are also expanding the reach of these devices.

Market Scope

Report Coverage

Details

Page number

176

Base year

2023

Historic period

2017-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 10.87%

Market growth 2024-2028

USD 10.87 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

9.53

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

Asia at 34%

Key countries

US, China, UK, Germany, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Agfa Gevaert NV, AnMo Electronics Corp., Baxter International Inc., Bayer AG, Bomtech Electronics Co. Ltd., Bruker Corp., Caliber Imaging and Diagnostics Inc, Canfield Scientific Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Firefly Global, FotoFinder Systems GmbH, General Electric Co., HEINE Optotechnik GmbH and Co. KG, Keyence Corp., KIRCHNER and WILHELM plus GmbH Co. KG, Michelson Diagnostics Inc., Microcurrent Technology Inc., and Strata Skin Sciences Inc

Market dynamics

Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global Dermatology Diagnostic Devices Market 2018 - 2022
      • Historic Market Size - Data Table on Global Dermatology Diagnostic Devices Market 2018 - 2022 ($ million)
    • 4.2 End-user segment analysis 2018 - 2022
      • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type segment analysis 2018 - 2022
      • Historic Market Size - Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography segment analysis 2018 - 2022
      • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country segment analysis 2018 - 2022
      • Historic Market Size - Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Bargaining power of buyers - Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Threat of new entrants - Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Threat of substitutes - Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Threat of rivalry - Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Chart on End-user - Market share 2023-2028 (%)
      • Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Chart on Comparison by End-user
      • Data Table on Comparison by End-user
    • 6.3 Hospitals - Market size and forecast 2023-2028
      • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 6.4 Clinics - Market size and forecast 2023-2028
      • Chart on Clinics - Market size and forecast 2023-2028 ($ million)
      • Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
      • Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 6.5 Diagnostic labs - Market size and forecast 2023-2028
      • Chart on Diagnostic labs - Market size and forecast 2023-2028 ($ million)
      • Data Table on Diagnostic labs - Market size and forecast 2023-2028 ($ million)
      • Chart on Diagnostic labs - Year-over-year growth 2023-2028 (%)
      • Data Table on Diagnostic labs - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Market opportunity by End-user ($ million)
      • Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Chart on Type - Market share 2023-2028 (%)
      • Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Chart on Comparison by Type
      • Data Table on Comparison by Type
    • 7.3 Imaging devices - Market size and forecast 2023-2028
      • Chart on Imaging devices - Market size and forecast 2023-2028 ($ million)
      • Data Table on Imaging devices - Market size and forecast 2023-2028 ($ million)
      • Chart on Imaging devices - Year-over-year growth 2023-2028 (%)
      • Data Table on Imaging devices - Year-over-year growth 2023-2028 (%)
    • 7.4 Microscopes - Market size and forecast 2023-2028
      • Chart on Microscopes - Market size and forecast 2023-2028 ($ million)
      • Data Table on Microscopes - Market size and forecast 2023-2028 ($ million)
      • Chart on Microscopes - Year-over-year growth 2023-2028 (%)
      • Data Table on Microscopes - Year-over-year growth 2023-2028 (%)
    • 7.5 Immunoassays - Market size and forecast 2023-2028
      • Chart on Immunoassays - Market size and forecast 2023-2028 ($ million)
      • Data Table on Immunoassays - Market size and forecast 2023-2028 ($ million)
      • Chart on Immunoassays - Year-over-year growth 2023-2028 (%)
      • Data Table on Immunoassays - Year-over-year growth 2023-2028 (%)
    • 7.6 Molecular diagnostics - Market size and forecast 2023-2028
      • Chart on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
      • Data Table on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
      • Chart on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
      • Data Table on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
    • 7.7 Others - Market size and forecast 2023-2028
      • Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Chart on Others - Year-over-year growth 2023-2028 (%)
      • Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by Type
      • Market opportunity by Type ($ million)
      • Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Chart on Market share by geography 2023-2028 (%)
      • Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Chart on Geographic comparison
      • Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Chart on North America - Year-over-year growth 2023-2028 (%)
      • Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Chart on US - Market size and forecast 2023-2028 ($ million)
      • Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Chart on US - Year-over-year growth 2023-2028 (%)
      • Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Chart on China - Market size and forecast 2023-2028 ($ million)
      • Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Chart on China - Year-over-year growth 2023-2028 (%)
      • Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Chart on UK - Year-over-year growth 2023-2028 (%)
      • Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 Germany - Market size and forecast 2023-2028
      • Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Market opportunity by geography ($ million)
      • Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Opportunity/Restraints

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market opportunities/restraints

          11 Competitive Landscape

          • 11.1 Overview
            • 11.2 Competitive Landscape
              • Overview on criticality of inputs and factors of differentiation
            • 11.3 Landscape disruption
              • Overview on factors of disruption
            • 11.4 Industry risks
              • Impact of key risks on business

            12 Competitive Analysis

            • 12.1 Companies profiled
              • Companies covered
            • 12.2 Market positioning of companies
              • Matrix on companies position and classification
            • 12.3 Agfa Gevaert NV
              • Agfa Gevaert NV - Overview
              • Agfa Gevaert NV - Business segments
              • Agfa Gevaert NV - Key news
              • Agfa Gevaert NV - Key offerings
              • Agfa Gevaert NV - Segment focus
            • 12.4 Baxter International Inc.
              • Baxter International Inc. - Overview
              • Baxter International Inc. - Business segments
              • Baxter International Inc. - Key news
              • Baxter International Inc. - Key offerings
              • Baxter International Inc. - Segment focus
            • 12.5 Bayer AG
              • Bayer AG - Overview
              • Bayer AG - Business segments
              • Bayer AG - Key news
              • Bayer AG - Key offerings
              • Bayer AG - Segment focus
            • 12.6 Caliber Imaging and Diagnostics Inc
              • Caliber Imaging and Diagnostics Inc - Overview
              • Caliber Imaging and Diagnostics Inc - Product / Service
              • Caliber Imaging and Diagnostics Inc - Key offerings
            • 12.7 Canfield Scientific Inc.
              • Canfield Scientific Inc. - Overview
              • Canfield Scientific Inc. - Product / Service
              • Canfield Scientific Inc. - Key offerings
            • 12.8 F. Hoffmann La Roche Ltd.
              • F. Hoffmann La Roche Ltd. - Overview
              • F. Hoffmann La Roche Ltd. - Business segments
              • F. Hoffmann La Roche Ltd. - Key news
              • F. Hoffmann La Roche Ltd. - Key offerings
              • F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Firefly Global
              • Firefly Global - Overview
              • Firefly Global - Product / Service
              • Firefly Global - Key offerings
            • 12.10 FotoFinder Systems GmbH
              • FotoFinder Systems GmbH - Overview
              • FotoFinder Systems GmbH - Product / Service
              • FotoFinder Systems GmbH - Key offerings
            • 12.11 General Electric Co.
              • General Electric Co. - Overview
              • General Electric Co. - Business segments
              • General Electric Co. - Key news
              • General Electric Co. - Key offerings
              • General Electric Co. - Segment focus
            • 12.12 HEINE Optotechnik GmbH and Co. KG
              • HEINE Optotechnik GmbH and Co. KG - Overview
              • HEINE Optotechnik GmbH and Co. KG - Product / Service
              • HEINE Optotechnik GmbH and Co. KG - Key offerings
            • 12.13 Keyence Corp.
              • Keyence Corp. - Overview
              • Keyence Corp. - Product / Service
              • Keyence Corp. - Key offerings
            • 12.14 KIRCHNER and WILHELM plus GmbH Co. KG
              • KIRCHNER and WILHELM plus GmbH Co. KG - Overview
              • KIRCHNER and WILHELM plus GmbH Co. KG - Product / Service
              • KIRCHNER and WILHELM plus GmbH Co. KG - Key offerings
            • 12.15 Michelson Diagnostics Inc.
              • Michelson Diagnostics Inc. - Overview
              • Michelson Diagnostics Inc. - Product / Service
              • Michelson Diagnostics Inc. - Key offerings
            • 12.16 Microcurrent Technology Inc.
              • Microcurrent Technology Inc. - Overview
              • Microcurrent Technology Inc. - Product / Service
              • Microcurrent Technology Inc. - Key offerings
            • 12.17 Strata Skin Sciences Inc
              • Strata Skin Sciences Inc - Overview
              • Strata Skin Sciences Inc - Business segments
              • Strata Skin Sciences Inc - Key offerings
              • Strata Skin Sciences Inc - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Inclusions checklist
                • Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Currency conversion rates for US$
              • 13.4 Research methodology
                • Research methodology
              • 13.5 Data procurement
                • Information sources
              • 13.6 Data validation
                • Data validation
              • 13.7 Validation techniques employed for market sizing
                • Validation techniques employed for market sizing
              • 13.8 Data synthesis
                • Data synthesis
              • 13.9 360 degree market analysis
                • 360 degree market analysis
              • 13.10 List of abbreviations
                • List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Dermatology Diagnostic Devices market growth will increase by $ 10867.4 mn during 2024-2028 .

              The Dermatology Diagnostic Devices market is expected to grow at a CAGR of 10.87% during 2024-2028 .

              Dermatology Diagnostic Devices market is segmented by End-user( Hospitals, Clinics, Diagnostic labs, Molecular diagnostics, Others) Type( Imaging devices, Microscopes, Immunoassays, Molecular diagnostics, Others)

              Abbott Laboratories, Agfa Gevaert NV, AnMo Electronics Corp., Baxter International Inc., Bayer AG, Bomtech Electronics Co. Ltd., Bruker Corp., Caliber Imaging and Diagnostics Inc, Canfield Scientific Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Firefly Global, FotoFinder Systems GmbH, General Electric Co., HEINE Optotechnik GmbH and Co. KG, Keyence Corp., KIRCHNER and WILHELM plus GmbH Co. KG, Michelson Diagnostics Inc., Microcurrent Technology Inc., Strata Skin Sciences Inc are a few of the key vendors in the Dermatology Diagnostic Devices market.

              Asia will register the highest growth rate of 34% among the other regions. Therefore, the Dermatology Diagnostic Devices market in Asia is expected to garner significant business opportunities for the vendors during the forecast period.

              US, China, UK, Germany, Japan

              • Increasing prevalence of melanoma and autoimmune skin diseasesThe growing prevalence of skin disorders and abnormalities is increasing the need for diagnosis. The use of dermatology diagnostic devices is gaining popularity owing to the increase in the prevalence of skin disorders. Skin disorders are among the most common health problems globally and are collectively exceeding the prevalence of conditions such as hypertension is the driving factor this market.
              • cancer is the driving factor this market.
              • and obesity. Autoimmune skin disorders are caused due to the abnormal immune response of the body against foreign substances. This is known as autoimmunity is the driving factor this market.
              • and diseases acquired usually fluctuate between periods of flare-ups and remission. According to the National Psoriasis Foundation is the driving factor this market.
              • psoriasis is an autoimmune skin disease that affects more than 3% of the US adult population. Some autoimmune disorders are scleroderma is the driving factor this market.
              • epidermolysis bullosa is the driving factor this market.
              • and dermatomyositis Skin cancer affects more than 1.3 million people in the US alone. According to the National Cancer Institute is the driving factor this market.
              • the percentage of new cases of melanoma is 22.8% per 100 is the driving factor this market.
              • 000 men and women every year is the driving factor this market.
              • and the death rate is 2.3% per 100 is the driving factor this market.
              • 000 men and women per year. These rates are an epidemiological study of age-adjusted and based on 2014 to 2018 cases and deaths. This concluded that the prevalence of non-melanoma skin cancer is increasing. Melanoma is the least common type of skin cancer is the driving factor this market.
              • but it is more complicated and more likely to be fatal. Melanoma contributes to approximately 2% of the total skin cancers in the population and remains a major cause of morbidity and mortality across the world. The survival rate for melanoma has decreased in the last few years due to the lack of early detection. In the UK is the driving factor this market.
              • nearly 16 is the driving factor this market.
              • 200 people suffer from melanoma each year. The incidence rates of melanoma are highest in people aged 85 to 89 in the UK. Early diagnosis and prevention are the most important strategies for minimizing the impact of this disease. Such factors are expected to drive the demand for dermatology diagnostics devices is the driving factor this market.
              • which is the driving factor this market.
              • in turn is the driving factor this market.
              • will boost the growth of the global dermatology diagnostic devices market during the forecast period. is the driving factor this market.

              The Dermatology Diagnostic Devices market vendors should focus on grabbing business opportunities from the Hospitals segment as it accounted for the largest market share in the base year.